NCT02305797View on ClinicalTrials.gov

EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD)

PHASE3CompletedINTERVENTIONAL
Enrollment

495

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Generalized Anxiety Disorder (GAD)
Interventions
DRUG

Extended-release lorazepam

Extended-release lorazepam capsules

DRUG

Placebo

Placebo capsules

Trial Locations (1)

Unknown

Multiple Investigational Sites, Multiple Locations

Sponsors
All Listed Sponsors
lead

Edgemont Pharmaceuticals, LLC

INDUSTRY